Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: A subanalysis from the DEDICATE-DZHK6 trial

1 September 2024 (09:11 - 09:22)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Professor Sabine Bleiziffer

Heart Centre Central Clinic Bad Berka, Bad Berka (Germany)

7 More presentations in this session

Presentation thumbnail

Effect of Aficamten on Cardiac Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM CMR Trial

Doctor A. Masri (Portland, US)

Presentation thumbnail

Effect of Aficamten on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

Doctor J. Spertus (Kansas City, US)

Presentation thumbnail

Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Doctor S. Hegde (Dallas, US)

Presentation thumbnail

Safety and Outcomes of Standard of Care Medications Withdrawal in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in FOREST-HCM Trial

Doctor A. Masri (Portland, US)

Presentation thumbnail

Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis

Associate Professor M. Banovic (Belgrade, RS)

Access the full session

Session thumbnail

Trial updates and other studies in hypertrophic cardiomyopathy and aortic stenosis

The Event

Event poster

ESC Congress 2024

1 September 2024 09:11 CET

You may be interested in

Congress Session

Aortic stenosis in females: the impact of the RHEIA trial on clinical practice

Congress Presentation

Sex-specific considerations of TAVI

Congress Presentation

Sex-based differences in outcomes of transcatheter aortic valve replacement: a meta-analysis and meta-regression of 657,850 patients

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources